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ABSTRACT 
 
Echocardiography can detect cardiac morphologic and hemodynamic change caused by systemic arterial 
hypertension, echocardiography is a powerful tool for the evaluation of target organ damage, which is essential for 
the evaluation of cardiovascular risk. This study was conducted at Kamineni Institute of Medical Sciences, 
Narkatpally,Telangana State. The aim of this study was Echocardiographic evaluation of cardiac status in systemic 
hypertension patients. All patients of systemic hypertension whose diastolic blood pressure was persistently over 
90mm Hg, were selected for study. This includes 50 hypertensive patients of age 30-60 years of both sexes. There 
were 33 males and 17 female. Hypertension was more common in mean age of 49 years, males are mostly effected 
than females. Left ventricular hypertrophy seen in 76% of patients, 58% of patients have diastolic dysfunction,6% 
patients have systolic dysfunction and 12% had both systolic and diastolic dysfunction. About 24% had no left 
ventricular dysfunction. Congestive heart failure was seen in 10% of patients, among them 4% with LV diastolic 
dysfunction, 2%systolic dysfunction and 4% with both dysfunctions were noticed. 
 
Keywords: Echocardiography, systemic hypertension, left ventricular hypertrophy, Congestive heart failure, 
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Introduction 
 
 
Hypertensive heart disease is the target organ response 
to systemic arterial hyper-tension. Patients with 
longstanding hypertension are at increased risk for 
developing left ventricular hypertrophy (LVH) and 
diastolic dysfunction [1]. Diastolic dysfunction is the 
earliest evidence of involvement of heart in 
hypertension. This is not pathognomic of hypertensive 
heart disease, as similar changes may be present in 
aged persons or patients having coronary artery 
disease, unrelated to hypertension. Left ventricular 
hypertrophy (LVH) is therefore considered as a hall 
mark of hypertensive heart disease, as systolic 
dysfunction usually appears late in course of disease. 
____________________________ 
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 Patients with left ventricular hypertrophy have 
increased risk of angina pectoris, acute coronary 
syndrome, ventricular arrhythmias, sudden cardiac 
death (SCD) and congestive cardiac failure. Thus LVH 
has emerged as an independent risk factor for further 
adverse event unreleased to stage of hypertension. 
Arterial hypertension associated to LV concentric 
remodeling is the determinant of diastolic dysfunction 
but several other cardiac diseases, including 
myocardial ischaemia, and extra cardiac pathologies 
involving the heart are other possible causes. Arterial 
hypertension represents one of the most common risk 
factors for the development of heart failure, conferring 
approximately a twofold increased risk in men and a 
threefold risk in women relative to normotensive 
subjects [2].An early detection and prevention of LV 
dysfunction is an important goal in the management of 
hypertensive patient. A number of anti-hypertensive 
agents are available which not only controls BP 
effectively but also reduces the risk factors associated 
with cardiac dysfunction. Non-invasive investigations 
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that would provide an assessment of left ventricular 
status are chest X-ray, ECG, Radio nuclide 
ventriculography and echocardiography. 
Echocardiography provides a simple, safe, reproducible 
and accurate method and modality of choice to define 
left ventricular hypertrophy and dysfunction. The aim 
of this study is Echocardiographic evaluation of cardiac 
status in systemic hypertension patients  
 
Materials and methods  
 
This study is conducted at Kamineni institute of  
Medical sciences, Narkatpally, Telangana state after 
obtaining the permission from the hospital ethics 
committee  from January 2016 to December 2017. 
Systemic hypertension  Patients  coming to the Medical 
OPD were included in this study. 
Patient's age, sex, occupational history is noticed. 
Patients are enquired about their habits like alcohol 
intake, smoking, tobacco and gutka chewing. Family 
history of hypertension, diabetes, obesity, angina, 
dyspnoea, headache, myocardial infarction, weight 
loss, hematuria, drug history other relevant history was 
taken. 
All patients of systemic hypertension whose diastolic 
blood pressure was persistently over 90mm Hg, were 
selected for study. But hypertensive patients with 
coexistent ischemic heart disease, congenital and 
acquired heart disease, corpulmonale, pregnancy with 
toxaemia, hyperdynamic circulatory states, chronic 
renal failure and cardiomyopathies were excluded, as 
these ontheir own accord, are likely to alter the 
function of the heart. 
Patient’s routine investigations like blood sugar, blood 
urea, serum creatinnie, Hb, CBC, urine routine and 
microscopy, X-ray chest, 12 lead ECG and lipid profile 
were done. 
All selected patients will be subjected to 
echocardiography. The left ventricular dysfunction was 
assessed by  
1) Left Ventricular Hypertrophy (LVH)  
2) Diastolic dysfunction 
 3) Systolic dysfunction 
Left Ventricular Hypertrophy: There are two 
methods of calculating LV mass from 2D 
echocardiography.  
a) Area length method 
b) Truncated ellipsoid method 
For both methods require short axis view of left 
ventricle at papillary muscle level and apical four or 
two chamber at end diastole are required. Myocardial 
mass is equal to product of volume and specific gravity 
of myocardium (1.04 gm/ml).Built in software in 
ultrasound can make both methods available so that 
mass is automatically calculated, once all variables are 
fed. LV mass can also be estimated from 2D guided, M 
mode measurements of LV dimension and wall 
thickness at papillary muscle level without measuring 
left ventricular major axis, Dimension and simple 
geometric cube formula.  
The following equation provides an accurate 
determination of LV mass, according to Devereux et al 
[3]  
 Left ventricular mass (gms) = 1.04 (LVID + PWT + 
IVST)° - LVID® x 0.8 + 0.6 
where 1.04 specific gravity of myocardium 0.8 
correction factor 
LVID — Left ventricular internal dimension 
PWT — Posterior wall thickness 
IVST — Interventricular septal thickness measured at -
end diastole  
 
Diastolic dysfunction 
Based on Doppler velocity pattern, diastole dysfunction 
is divided into three categories 
 a) Relaxation abnormalities b) Restrictive physiology 
c) Pseudonormalization 
Relaxation abnormalities: Abnormal myocardial 
relaxation characterized by constellation of following 
abnormalities 
Prolonged IVRT (lsovolumic relaxation time) > 110 
m/sec, 
 Low E velocity (early filling velocity)  
 high A velocity (A velocity = Late filling velocity) 
Revised E/A ratio (<1.0)% 
Prolonged deceleration time (DT) > 240 m/sec 
Restrictive physiology: is characterized by following 
diastolic parameters 
Shortened IVRT ( <60 msec) 
High E velocity and low velocity  
Increased E/A ratio > 2 
Shortened deceleration time (< 150 msec)  
 
Systolic dysfunction 
To evaluate systolic two parameters are used , 
Fractional shortening or ejection fraction and Cardiac 
output. 
Fractional shortening is percentage change in left 
ventricle cavity dimension with systolic contraction 
and can be calculated from following equation.  
Fractional shortening = LVED-LVES) / LVED x 100%  
Where LVES — LV end systolic dimension  
         LVED — LV end diastolic dimension 
Ejection fraction represents stroke volume as percent 
of end diastolic left ventricular volume.  
Ejection fraction = (EDV - ESV) / E «100%  
Where EDV - End diastolic volume of LV  
ESV - End systolic volume of LV 
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Quninomers and co authors proposed a simplified 
method for determination of ejection fraction by 
measuring LV internal dimensions  
Ejection fraction = (% AD’) + [C1 -% DA] [%AL]  
Where   % AD = [(LVED — LVES) / LVED*] x 
100%. 
 
Results  
 
The present study was conducted in 50 hypertensive patients of age 30-60 years of both sexes. There were 33 males 
and 17 female.  Age wise and sex wise distribution of hypertensive patients were shown in table 1. 
 
Table 1: Age and Sex distribution of hypertensive cases 
 
S. No Age group Males (No & %) Females (No & %) Total (No & %) 
1 31-40 8(16%) 2(4%) 10(20%) 
2 41-50 10(10%) 4(8%) 14(28%) 
3 51-60 11(22%) 7(14%) 18(36%) 
4 61-70 4(8%) 4(8%) 8(16%) 
  33(66%) 17(34%) 50(100%) 
 
Table 2: Prevalence of left ventricular dysfunction in hypertensive patients with or without congestive heart 
failure (CHF) 
 
S.No Dysfunction No of cases (%) 
1 Only diastolic dysfunction 29(58%) 
2 Only systolic dysfunction 3(6%) 
3 Both systolic & diastolic dysfunction 6(12%) 
4 No LV dysfunction 12(24%) 
5 Total diastolic dysfunction 35(70%) 
6 Total systolic dysfunction 9(18%) 
Left Ventricular dysfunction was present in 76% of hypertensive patients and 24% does not show dysfunction.  Six 
patients have had both systolic and diastolic dysfunction. Out of 50 cases of hypertension 10% patients i.e. 5 of them 
presented with CHF. Among them 2 with LV diastolic dysfunction, 1systolic dysfunction and 2 with both 
dysfunction were noticed.  In all diastolic dysfunction patients EF slope was reduced and E/A ratio altered.  In 
echocardiographic findings of patients with systolic dysfunction there were reduced LV Ejection Fraction(LVEF), 
increased  LV Internal Dimensions (LVID) in diastole and systole were observed. Increased LV dimension and 
reduced ejection fraction was present in all the cases of systolic dysfunction.  
Table 3: Electrocardiographic findings 
 
Total diastolic dysfunction(n=35) Total systolic dysfunction(n=9) 
EF slope reduced Increased LV dimension 
E/A ratio altered reduced ejection fraction 
 
Table  4: Comparison of LVH detected by X-ray, ECG and echocardiography 
 
Method No of cases LVH detected 
Chest X-ray 2(4%) 
ECG 6(12%) 
Echocardiography 30(60%) 
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Table 5: Correlation between LV dysfunction and duration of hypertension 
 
S.No Duration in years  No of hypertensive patients  hypertensive patients 
with  systolic 
dysfunction (n=9) 
hypertensive 
patients with  
diastolic 
dysfunction(n=35) 
1 >5 16(32%) 4(8%) 12(24%) 
2 5 to10 15(30%) 1(2%) 14(28%) 
3 <10 13(26%) 4(8%) 9(18%) 
 
Table  6: LV dysfunction in hypertensive patients of different age groups 
S. No Age group No of hypertensive 
patients  
hypertensive 
patients with  
systolic 
dysfunction 
(n=9) 
hypertensive patients 
with  diastolic 
dysfunction(n=35) 
1 31-40 10(20%) 1(2%) 5(10%) 
2 41-50 14 (28%) 2(36%) 10(20%) 
3 51-60 18(36%) 5(36%) 13(26%) 
4 61-70 8(16%) 1(36%) 7(14%) 
 
Table 7: LVH in hypertensive patients of different age groups 
 
S. No Age group No. of  hypertensive patients  Hypertensive with LVH 
1 31-40 10(20%) 6(12%) 
2 41-50 14(28%) 9(18%) 
3 51-60 18(36%) 15(30%) 
4 61-70 8(16%) 8(16%) 
  
Table 8: Correlation between severity of hypertension and LVH 
 
S.No Severity of Hypertension hypertensive patients with  
systolic dysfunction (n=9) 
hypertensive patients with  diastolic 
dysfunction(n=35) 
 Prehypertension 3 (6%) 14(28%) 
 Stage I 0 11(22%) 
 Stage II 6(12%) 10(20%) 
 
In patients with diastolic dysfunction 30% had 
unsatisfactory BP control and Patients with both 
diastolic and systolic dysfunction (12%) does not have 
satisfactory BP control but patients with only systolic 
dysfunction had satisfactory BP control. 
 
Discussion 
 
The end of natural history of untreated hypertension is 
an increased likelihood of premature disability or death 
from cardiovascular diseases. The pathogenesis of 
hypertension involves structural changes in the 
resistance arterioles described under term remodeling 
and hypertrophy. Hypertrophic remodeling clearly 
develops in larger arteries as an early manifestation of 
essential hypertension with close symmetry between 
vascular and cardiac hypertrophy. 
Diastolic and systolic dysfunctions have been observed 
early in the course of hypertension and either or both 
may lead to heart failure. Such diastolic dysfunction 
may reflect more vigorous atrial emptying or abnormal 
diastolic relaxation. The earliest function cardiac 
changes in hypertension are in left ventricular diastolic 
function, with lower E/A ratio and longer isovolemic 
relaxation time [4]. Cardiovascular diseases are major 
leading health problems in the world [5], and 
hypertension is a major risk factor for cardiovascular 
diseases and stroke which have significantly higher 
morbidity and mortality [6]. Although the 
echocardiographic examination is usually 
recommended as a second-line study in the evaluation 
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of hypertensive patients, it is one of most commonly 
used imaging modality and has given insights into 
pathophysiology and clinical implications in patients 
with hypertension. It can detect anatomical and 
functional changes easily in a real-time, quick, and 
reproducible manner. Echocardiography is more 
sensitive for the detection of asymptomatic organ 
damage that can be used as a determinant of 
cardiovascular risk. So, it is important in the clinical 
management in selected hypertensive patients [7] 
In the 2013 ESH/ESC Guidelines for the management 
of arterial hypertension, echocardiography is the 
second-line study based on medical history, physical 
examination, and findings from routine laboratory tests 
[8]. The guidelines recommended performing 
echocardiographic examination in patients who are 
suspected with having left ventricular hypertrophy 
(LVH), left atrial (LA) dilatation, or concomitant heart 
diseases .The 2014 Canadian Hypertension Education 
Program (CHEP) guidelines recommended the 
echocardiographic use in the selected patients [9]. 
Routine echocardiographic study is not recommended 
in all patients with hypertension (grade D: 
recommendations are based on expert opinion alone). 
However, the echocardiographic examination for the 
evaluation of LVH is useful in selected patients to 
define the future cardiovascular risk (grade C: 
recommendations are based on trials that have lower 
levels of internal validity and/or precision, trials 
reporting invalidated surrogate outcomes, or results 
from non-randomized observational studies). 
We have chosen echocardiography as this can be 
employed safely in any setting without patient 
preparation, discomfort and convenience. This is non-
invasive economical and can be repeated any number 
of times. Hypertension noticed in patients aged from 
31-68 years with mean of 49 years, maximum numbers 
of cases were between 41-60 years being equally 
divided in 5th and 6th decades. In these patients ECG 
indicated LVH in only 6cases (12%) while radiography 
was even a poorer parameter which suggested LVH in 
only two cases (4%). Echocardiography therefore, was 
found to be far superior method. 
Hypertensive left ventricular hypertrophy (LVH) 
represents a powerful predictor for cardiovascular 
morbidity and mortality, independent of other 
cardiovascular risk factors, even blood pressure itself. 
A normal ECG does not exclude the presence of LVH, 
and therefore patients should be evaluated further with 
imaging. Echocardiography is clinically useful in the 
detection of LVH and the assessment of diastolic 
function.[1] 
In our study  76% patients suffering with LVH. I n our 
study 70% of patients were with diastolic dysfunction 
showed EF slope is reduced and alteration in E/A ratio 
less than one. Echocardiography is a useful imaging 
tool to measure LV diastolic function. Several 
echocardiographic modalities can be used to estimate 
LV filling pressure. Increased LA size and volume is 
one of indicator of increased LV filling pressure 
[10,11]. Enlarged LA diameter was found more than 
20% of hypertensive patients in a large-scale study 
including a total of 2,500 uncomplicated essential 
hypertensives [12]. Enlarged LA can present long-
standing elevated LV filling pressure, and increased 
LA size and volume were associated with poor long-
term mortality and morbidity [13,14].  LV diastolic 
dysfunction is associated with increased mortality in 
middle-aged and elderly adults[15].  
In our study 18% patients with severe systolic 
dysfunction showed reduced LVEF, increased LVIDd 
and Increased ‘ LVIDs ‘values were observed. 
Increased LV dimension and reduced ejection fraction 
was present in all the cases of systolic dysfunction. 
Several echocardiographic indices have been 
introduced to estimate LV systolic function. Among 
them, LVEF is the most used and the most practical 
systolic index that has been used as a prognostic factor 
in various cardiovascular diseases [16,17] 
Out of 50 cases of hypertension 10% patients i.e. 5 of 
them presented with CHF. Among them 2 with LV 
diastolic dysfunction, 1systolic dysfunction and 2 with 
both dysfunctions were noticed.  
Echocardiography provides a reliable, non invasive and 
sensitive method for detecting accurately LVH and LV 
systolic and diastolic dysfunction, which have 
important diagnostic, therapeutic and prognostic 
implications inpatients of systemic hyper tension  
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